Biocorrx Inc (PK:BICX)

Business Focus: Healthcare Facilities & Services

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BICX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 2/20 Mar 31/20 Felix Lourdes Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Emry Kent Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Ingargiola Luisa Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Lucido Louis C. Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Granier Brady James Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Jan 13/20 Dec 31/19 Emry Kent Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Felix Lourdes Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Ingargiola Luisa Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Granier Brady James Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Lucido Louis C. Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BICX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 2/20 Mar 31/20 Felix Lourdes Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Emry Kent Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Ingargiola Luisa Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Lucido Louis C. Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Apr 2/20 Mar 31/20 Granier Brady James Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 2,641  
Jan 13/20 Dec 31/19 Emry Kent Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Felix Lourdes Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Ingargiola Luisa Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Granier Brady James Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Jan 13/20 Dec 31/19 Lucido Louis C. Direct Ownership Common Stock, par value $0.001 A - Grant, award or other under Rule 16b-3(d) 1,818  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BICX

Competitors

Competitors with Recent Insider Filings
Quest Diagnostics (N:DGX)
CVS Health (N:CVS)
Chemed (N:CHE)